Lung Cancer Screening and Approach to the Lung Nodule

Brigham and Women's Hospital

A. Ramaswamy

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

Lung Cancer Screening

Kyle Hogarth

WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion

Insights from 2024 WCLC

P. Lee

Year in Review: Lung Cancer

Balazs Halmos

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Cancer Screening Molecular Tools

Fengting Yan

Key to Successful Lung Cancer Screening and Lung Nodule Program

University of Colorado Department of Medicine

N. Thomas

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

Metaphorical Signs in Computed Tomography of Chest

Atul C. Mehta

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Total Health

W. Iams

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Mediastinal Staging of Lung Cancer

MI&T Congressi

R. Trisolini

Staging Disease: How Oncologists Stage NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

Metastatic EGFRm NSCLC: 1L Therapy Options

University of Colorado Cancer Center

T. Patil

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical Implicat…

Insights from 2023 ASCO® Annual Meeting

J. West

Approach to Screening and Nodule Surveillance Program

Weill Cornell Medicine Cardiothoracic Surgery

B. Pua

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

ecancer

E. Felip, A. Spira, A. Passaro, A. Addeo

Multidisciplinary Panel Discussion: New Treatment Options for Surgic…

David Carbone

B. Stiles

The Role of Molecular Biomarkers for Lung Nodule Evaluation

Cleveland Clinic Respiratory Institute

P. J Mazzone